Passage Raises $4M To Help Developers Bring Biometric Authentication To The Masses
PUBLIC · PASGFeb 01, 2022
Amount Raised
$4 Million
Round Type
Seed
United StatesBiotechnologyHealthcareHealth CareGeneticsTherapeutics
Description
Passage, an innovator in the rapidly growing passwordless identity space, today emerged from stealth announcing the availability of its public beta along with $4 million of new funding led by LiveOak Venture Partners with participation from Next Coast Ventures, Tau Ventures, Secure Octane, and various angel investors. Passage takes a developer-first and biometric-first approach to passwordless authentication, enabling users to log in to web applications with Face ID, Touch ID, Windows Hello, and other biometrics built into their devices.
Company Information
Company
Passage Bio
Location
United States
About
Passage Bio, Inc. (NASDAQ: PASG) is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases.
Fundz sees it the moment Passage Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.